As Co-President of Orange Biomed, Yeaseul Park plays a pivotal role in steering the company towards its mission of revolutionizing diabetes management through innovative technology. With a solid academic foundation in Psychology from Yonsei University and an MBA from Duke University, Yeaseul combines her understanding...
As Co-President of Orange Biomed, Yeaseul Park plays a pivotal role in steering the company towards its mission of revolutionizing diabetes management through innovative technology. With a solid academic foundation in Psychology from Yonsei University and an MBA from Duke University, Yeaseul combines her understanding of human behavior with strategic business acumen to drive impactful healthcare solutions.
Since the inception of Orange Biomed in 2021, Yeaseul has been instrumental in the development and launch of a cutting-edge point-of-care diagnostic device designed to accurately measure A1c levels. This breakthrough technology not only enhances the precision of diabetes management but also empowers patients to take control of their health in real-time. Under her leadership, the company has successfully navigated the complexities of research and development, fostering cross-functional team collaboration to bring this innovative product to market.
Yeaseul's expertise in research, strategy, and business development has been critical in establishing Orange Biomed as a leader in the healthcare technology sector. She has spearheaded key projects that leverage advanced medical technologies, ensuring that the company's offerings are not only scientifically robust but also user-friendly. Her commitment to improving the quality of life for individuals living with chronic diseases is evident in every aspect of her work, as she strives to bring both health and happiness to those affected by diabetes. With a keen focus on project management and a passion for innovation, Yeaseul Park continues to shape the future of diabetes care, making a lasting impact in the healthcare industry.
